OncoMed Pharmaceuticals Inc Stock Split Ratio
OncoMed Pharmaceuticals Inc reported Stock Split Ratio of 17.50% for the 1-month period ending 2013-07-17, per its 10-Q filed 2013-11-13.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2014-03-18
- 2013-07-17: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 17.50%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 17.50%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2013-07-17 | 17.50% 10-K · filed 2014-03-18 | 17.50% 10-Q · filed 2013-11-13 |